KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) Net Margin (2016 - 2025)

Elevance Health (ELV) has disclosed Net Margin for 16 consecutive years, with 1.11% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 20.0% to 1.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 2.85% through Dec 2025, down 66.0% year-over-year, with the annual reading at 2.87% for FY2025, 51.0% down from the prior year.
  • Net Margin for Q4 2025 was 1.11% at Elevance Health, down from 2.34% in the prior quarter.
  • The five-year high for Net Margin was 6.31% in Q2 2021, with the low at 0.91% in Q4 2024.
  • Average Net Margin over 5 years is 3.94%, with a median of 4.24% recorded in 2021.
  • The sharpest move saw Net Margin skyrocketed 351bps in 2021, then plummeted -339bps in 2023.
  • Over 5 years, Net Margin stood at 3.83% in 2021, then skyrocketed by 38bps to 5.29% in 2022, then crashed by -64bps to 1.91% in 2023, then crashed by -52bps to 0.91% in 2024, then increased by 22bps to 1.11% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 1.11%, 2.34%, and 3.53% for Q4 2025, Q3 2025, and Q2 2025 respectively.